Rankings
▼
Calendar
BBLG FY 2019 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena
BBLG
Bone Biologics Corporation
$2M
FY 2019 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$0
Gross Profit
-$50
Operating Income
-$2M
Net Income
-$3M
EPS (Diluted)
$-66.97
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$49,692
Balance Sheet
Total Assets
$30,827
Total Liabilities
$12M
Stockholders' Equity
-$12M
Cash & Equivalents
$24,145
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$50
-$96
+47.9%
Operating Income
-$2M
-$3M
+12.3%
Net Income
-$3M
-$4M
+22.7%
← Q4 2018
All Quarters
Q1 2019 →